Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
01/06ASTELLAS PHARMA INC. : - FDA Accepts for Priority Review the New Drug Applicatio..
AQ
2020ASTELLAS PHARMA : FDA Lifts Clinical Hold for Audentes Therapeutics' AT132 Trial
MT
2020ASTELLAS PHARMA : Reports XOSPATA in Combination with Azacitidine Did Not Meet E..
AQ
2020ASTELLAS PHARMA : Supports Recommendations of Task Force on Climate-related Fina..
AQ
2020ASTELLAS PHARMA INC. : - Expansion of the Domestic Logistics Platform for Pharma..
AQ
2020Astellas Pharma, Viatris Pharmaceuticals Japan to End Joint Sales Promotion o..
MT
2020Astellas Receives Approval of EVRENZO in Japan for the Treatment of Anemia of..
AQ
2020Astellas Europe Transfers DIFICLIR Market Authorizations in EMEA, Select CIS ..
MT
2020Astellas Pharma Gets Approval for EVRENZO in Japan
MT
2020ASTELLAS PHARMA : Launches a 'Contact for Potential Acquisition of ' R&D Program..
AQ
2020ASTELLAS PHARMA : to Present New Data on Gilteritinib in FLT3 Mutation-Positive ..
AQ
2020Astellas Pharma in Absorption-Type Merger with Two Subsidiaries
MT
2020ASTELLAS PHARMA INC. : - XTANDI Approved by China NMPA for the Treatment of Non-..
AQ
2020ASTELLAS PHARMA : Completes Acquisition of iota Biosciences
AQ
2020Astellas Pharma Acquires Iota Biosciences
MT
More most relevant news
All news about ASTELLAS PHARMA INC.
01/14ACTINIUM PHARMACEUTICALS : and Astellas Announce Research Collaboration Focused ..
AQ
01/06ASTELLAS PHARMA INC. : - FDA Accepts for Priority Review the New Drug Applicatio..
AQ
2020ASTELLAS PHARMA : FDA Lifts Clinical Hold for Audentes Therapeutics' AT132 Trial
MT
2020ASTELLAS PHARMA : Reports XOSPATA in Combination with Azacitidine Did Not Meet E..
AQ
2020ASTELLAS PHARMA : Supports Recommendations of Task Force on Climate-related Fina..
AQ
2020ASTELLAS PHARMA INC. : - Expansion of the Domestic Logistics Platform for Pharma..
AQ
2020VIATRIS : Astellas and Viatris Announce Termination of Co-promotion, Succession ..
AQ
2020Japan shares slip for third day; all eyes on U.S. stimulus debate
RE
2020Japanese shares slip back as investors look to U.S. stimulus debate
RE
2020Astellas Pharma, Viatris Pharmaceuticals Japan to End Joint Sales Promotion o..
MT
More news
News in other languages on ASTELLAS PHARMA INC.
2020ASTELLAS PHARMA INC. : Veröffentlichung des Halbjahresergebnisses
2020ASTELLAS PHARMA INC. : publication des résultats semestriels
2020ASTELLAS PHARMA INC. : publication des résultats trimestriels
2020ASTELLAS PHARMA INC. : Veröffentlichung des Quartalsergebnisses
2020Basileas klinische Studien liegen trotz Corona mehr oder weniger im Zeitplan
2020ASTELLAS PHARMA INC. : Veröffentlichung des Jahresergebnisses
2020ASTELLAS PHARMA INC. : publication des résultats annuels
2020Les Bourses asiatiques terminent en nette hausse, imitant Wall Street
2020Tokyo finit en hausse, dopée par Wall Street
2020Tokyo en nette hausse, dans le sillage de Wall Street
Press releases
01/14ACTINIUM PHARMACEUTICALS : and Astellas Announce Research Collaboration Focused ..
AQ
01/06ASTELLAS PHARMA INC. : - FDA Accepts for Priority Review the New Drug Applicatio..
AQ
2020ASTELLAS PHARMA : Reports XOSPATA in Combination with Azacitidine Did Not Meet E..
AQ
2020ASTELLAS PHARMA : Supports Recommendations of Task Force on Climate-related Fina..
AQ
2020ASTELLAS PHARMA INC. : - Expansion of the Domestic Logistics Platform for Pharma..
AQ
More press releases
Upcoming event on ASTELLAS PHARMA INC.